Concepedia
Statistics
Publications
3
Citations
115
H-Index
Active since
2022
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (South Korea)
AstraZeneca (Singapore)
AstraZeneca (Brazil)
Jacob Gordon is an author at AstraZeneca (United Kingdom) specializing in oncology, chemotherapy, and molecular oncology.
Publications per year
2022–2024
Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1
Anna D. Staniszewska, Domenic Pilger, Sonja J. Gill et al. · Clinical Cancer Research · 2023 · 58 citations
Medicine, Oncology, Pharmacology +14
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
Azadeh C. Bashi, Elizabeth A. Coker, Krishna C. Bulusu et al. · Cancer Discovery · 2024 · 37 citations · Full text
Medicine, Oncology, Pharmacology +10
Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair
Kunzah Jamal, Anna D. Staniszewska, Jacob Gordon et al. · Cancer Research · 2022 · 20 citations
Life Sciences, Molecular Biology, Oncology +17
1–3 of 3